Focal segmental glomerulosclerosis
1 paper
- Humans1
Trial sponsors
Company1 trialPhase 260 people
Company1 trialPhase 220 people
University Health Network, Toronto
1 trialPhase 410 people
Universitair Ziekenhuis Brussel
1 trialPhase 2/315 people
1 trialPhase 232 people
National Human Genome Research Institute
1 trialPhase 230 people
1 trialPhase 1/230 people
Latest
1 in 12 monthsClinical Journal of the American Society of Nephrology
Primary Glomerular Diseases in the Elderly: Clinical Features, Treatment Patterns, and Outcomes in the CureGN Cohort
Cohort study of 1,562 peoplePopulations